Gateway to Resources

Streamlining access to Medical Services

Welcome to Your Gateway to Resources: a unique portal from Cangene bioPharma that is designed to make it easier for you to achieve your everyday treatment goals by centralizing access to the most comprehensive
disease- and treatment-related information.

This portal will provide you with a virtual repository of information on immune thrombocytopenic purpura (ITP)
and hepatitis B virus (HBV) liver transplantation.

Our expertise will enhance your experience through a simplified route to current literature, patient assistance programs and reimbursement information, valuable
patient tools, and other dynamic features and benefits.

Healthcare Professionals/Products

Learn about WinRho® SDF

[RhO(D) Immune Globulin Intravenous (Human)]

Prescribing Information

Please click here for Important Risk Information

Learn about HepaGam B®

[Hepatitis B Immune Globulin Intravenous (Human)]

Prescribing Information

Please click here for Important Risk Information

Products & Services

Utilizing Your Gateway to Resources opens you up to a more efficient route to specific disease-related information.

Your Gateway features materials on treatment options, disease primers, key opinion leader discussions, slide programs/workbooks, and educational tools.

In addition, you can easily connect with real-time support on patient assistance programs, reimbursement guidance, medical/scientific affairs, and even request a visit from a Product Specialist.

Cangene bioPharma Specialty Products

Assistance

Patient Assistance Program

Reimbursement Assistance

For information and answers to questions about reimbursement for HepaGam B and WinRho SDF, please contact customer service at the toll-free numbers below:

1-877-HEPAGAMB
(1-877-437-2426)

1-800-4-WINRHO
(1-800-494-6746)

Reimbursement Card

Medical Education & Support

Distributors/Wholesalers

Distributors

ASD Healthcare,
AmerisourceBergen
Specialty Group

BDI Pharma

BioCare Medical

FFF Enterprises

Florida Infusion

McKesson Specialty,
Plasma & Biologics

National Hospital Specialties

Nōvis Pharmaceuticals

Oncology Supply,
AmerisourceBergen
Specialty Group

Wholesalers

AmerisourceBergen

Cardinal Health

H.D. Smith

McKesson

Morris Dickson

Therapeutic Expertise

As a leader in the marketing and distribution of plasma-derived products, Cangene bioPharma has collected an extensive volume of clinical data regarding the management of immune thrombocytopenic purpura (ITP) and the prevention of hepatitis B virus (HBV) recurrence following liver transplantation.

Your Gateway to Resources serves as an important online repository of clinical data with links to complementary information that will help support the management of your patients with these diseases.

ITP

ITP Educational Guide

Publications

A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Author: Andrew M, et al

Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect.
Author: Bussel J, et al

Standard-dose intravenous anti-D immunoglobulin versus intravenous immmunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Author: Papagianni A, et al

Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: The New York hospital experience.
Author: Scaradavou A.

Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Author: Tarantino MD, et al

Order publications through Medical Affairs

Liver Transplantation & HBV

Liver Transplant Educational Guide

Publications

Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation.
Author: Pauwelyn K, et al

Evaluation of blood glucose levels after hepatitis B immune globulin administration utilizing two different blood glucose monitoring systems.
Author: Shetty K, et al

HepaGam B after liver transplant in patients with hepatitis B virus.
Author: Terrault NA, et al

Order publications through Medical Affairs

Healthcare Professionals

Cangene bioPharma partners with healthcare professionals to provide valuable links to important clinical materials that will help to keep you informed about ITP and HBV liver transplantation.

Your Gateway to Resources can support you in achieving your treatment goals by providing product-specific and educational materials, as well as access to organizations that can be shared with your clinical team.

Medical Education

Programs

Management of ITP in Pediatrics: An Overview by Dr. Michael Tarantino

Accompanying Workbook

Disease Awareness

ITP Educational Guide

Liver Transplant Educational Guide

About WinRho® SDF

[RhO(D) Immune Globulin Intravenous (Human)]

Publications

A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Author: Andrew M, et al

Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect.
Author: Bussel J, et al

Standard-dose intravenous anti-D immunoglobulin versus intravenous immmunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Author: Papagianni A, et al

Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: The New York hospital experience.
Author: Scaradavou A.

Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Author: Tarantino MD, et al

Order publications through
Medical Affairs

About HepaGam B®

[Hepatitis B Immune Globulin Intravenous (Human)]

Publications

Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation.
Author: Pauwelyn K, et al

Evaluation of blood glucose levels after hepatitis B immune globulin administration utilizing two different blood glucose monitoring systems.
Author: Shetty K, et al

HepaGam B after liver transplant in patients with hepatitis B virus.
Author: Terrault NA, et al

Order publications through
Medical Affairs

Patient Management Tools

Pediatric ITP Patient Booklet

Post-Liver Transplant Resource Guide

Patient Diary/Appointment Book

Patient Assistance Program

Reimbursement Assistance

Reimbursement Card

Distributors/ Wholesalers

Distributors

ASD Healthcare, AmerisourceBergen
Specialty Group

BDI Pharma

BioCare Medical

FFF Enterprises

Florida Infusion

McKesson Specialty,
Plasma & Biologics

National Hospital Specialties

Nōvis Pharmaceuticals

Oncology Supply, AmerisourceBergen
Specialty Group

Wholesalers

AmerisourceBergen

Cardinal Health

H.D. Smith

McKesson

Morris Dickson

Contact Cangene

1-877-HEPAGAMB
(1-877-437-2426)

1-800-4-WINRHO
(1-800-494-6746)

Patient & Caregiver Resources

As a leader in the marketing and distribution of plasma-derived products, Cangene bioPharma recognizes the need to partner with healthcare professionals, patients, and caregivers to raise awareness of disease management.

Your Gateway to Resources provides valuable educational support for patients and caregivers to better understand the successful management of immune thrombocytopenic purpura (ITP) and the prevention of hepatitis B virus (HBV) recurrence following liver transplantation.

Reimbursement Assistance

For information and answers to questions about reimbursement for HepaGam B and WinRho SDF, please contact customer service at the toll-free numbers below:

1-877-HEPAGAMB
(1-877-437-2426)

1-800-4-WINRHO
(1-800-494-6746)

Reimbursement Card

Patient Assistance Program

Patients may qualify for temporary assistance for HepaGam B® or
WinRho® SDF therapy while
seeking alternative insurance
coverage. To inquire about
eligibility, please call

1-877-HEPAGAMB
(1-877-437-2426)

1-800-4-WINRHO
(1-800-494-6746)

About Cangene bioPharma

Cangene bioPharma was built on the premise of advancing the care of patients with rare diseases and conditions, by offering FDA-approved treatments, like WinRho® SDF [RhO(D) Immune Globulin Intravenous (Human)] and HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)].

In addition, with the goal of exceptional customer service, Your Gateway to Resources is structured so that you can share important clinical information about disease state management and the respective treatments with staff, patients, and caregivers.

Medical Affairs

medicalaffairs@cangene.com

Customer Service

customerservice@cangene.com

1-877-HEPAGAMB
(1-877-437-2426)

1-800-4-WINRHO
(1-800-494-6746)

Contact a Product Specialist

Request a callback or visit

customerservice@cangene.com

Distributors/Wholesalers

Distributors

ASD Healthcare,
AmerisourceBergen
Specialty Group

BDI Pharma

BioCare Medical

FFF Enterprises

Florida Infusion

McKesson Specialty,
Plasma & Biologics

National Hospital Specialties

Nōvis Pharmaceuticals

Oncology Supply,
AmerisourceBergen
Specialty Group

Wholesalers

AmerisourceBergen

Cardinal Health

H.D. Smith

McKesson

Morris Dickson

Connect to Cangene Corporation

www.cangene.com